A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients

Perit Dial Int. 2006 Jan-Feb;26(1):112-3; author reply 114.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Dialysis Solutions / chemistry*
  • Dialysis Solutions / therapeutic use*
  • Glycation End Products, Advanced / analysis*
  • Humans
  • Hydrogen-Ion Concentration
  • Kidney / drug effects
  • Kidney / physiopathology*
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy*
  • Peritoneal Dialysis*
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Treatment Outcome

Substances

  • Dialysis Solutions
  • Glycation End Products, Advanced